Hyperlipoproteinemias:

Indications for: TRILIPIX

Adjunct to diet to reduce TG in severe hypertriglyceridemia, and to reduce elevated LDL-C, Total-C, TG, and apo B, and to increase HDL-C in primary hypercholesterolemia or mixed dyslipidemia.

Limitations of Use:

Fenofibrate (at a dose equivalent to 135mg of Trilipix) did not reduce coronary heart disease morbidity and mortality in 2 controlled trials of patients with type 2 diabetes.

Adult Dosage:

Swallow whole. Take without regard to food. Primary hypercholesterolemia or mixed dyslipidemia: 135mg once daily. Hypertriglyceridemia: initially 45–135mg once daily. Titrate at 4–8week intervals; max 135mg/day. Mild to moderate renal impairment: initially 45mg once daily.

Children Dosage:

Not established.

TRILIPIX Contraindications:

Severe renal impairment including on dialysis. Active liver disease. Primary biliary cirrhosis. Unexplained persistent liver function abnormalities. Gallbladder disease. Nursing mothers (during and for 5 days after final dose).

TRILIPIX Warnings/Precautions:

The effect on coronary heart disease morbidity and mortality and non-cardiovascular mortality has not been established. Risk of serious liver injury. Monitor liver function at baseline and periodically during therapy; discontinue if liver injury develops or if elevated enzymes persist (ALT or AST >3×ULN, or if accompanied by elevated bilirubin); do not restart if no alternative explanation. Monitor CBCs during the first year. Discontinue if markedly elevated CPK levels, myopathy, gallstones, hypersensitivity reactions (acute and delayed), or paradoxical decreases in HDL-C occur (do not reinitiate). Diabetes. Hypothyroidism. Renal impairment: monitor. Elderly. Pregnancy.

TRILIPIX Classification:

Fibrate.

TRILIPIX Interactions:

Increased risk of myopathy/rhabdomyolysis with concomitant statins, colchicine. Potentiates warfarin (monitor PT/INR). Allow at least 1hr before or 4–6hrs after bile acid sequestrants. Risk of nephrotoxicity with immunosuppressants (eg, cyclosporine, tacrolimus), other nephrotoxic drugs.

Adverse Reactions:

Abnormal LFTs, increased AST/ALT, increased CPK, rhinitis; myopathy, rhabdomyolysis, hematological changes (eg, hgb, hct), increased serum creatinine, cholelithiasis, pancreatitis, hypersensitivity reactions (may be severe).

Generic Drug Availability:

YES

How Supplied:

Caps—90

Pricing for TRILIPIX

135mg capsule (Qty: 90)
Appx. price $80
GoodRx